AstraZeneca ships first doses of flu vaccine
Company will manufacture over 25% more doses than previously planned
Read MoreCompany will manufacture over 25% more doses than previously planned
Read MoreDeals agreed with Janssen and Novavax for another 90 million doses
Read MoreFunding will support development of novel antifungal asset olorofim
Read MoreIf approved drug would offer a more flexible option for patients
Read MorePublic trial will launch today in Isle of Wight and other locations
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
